Results 351 to 360 of about 193,970 (395)

Biliary Tract Cancer

2006
AbstractThis chapter reviews the epidemiology of biliary tract cancer. Many etiologic leads for biliary tract cancer have come from clinical observations, autopsy series, and descriptive epidemiologic studies. While a significant fraction of these tumors are related to gallstones (cholelithiasis), information on other risk factors is limited, due to ...
ANN W. HSING, ASIF RASHID, SUSAN S. DEVESA, JOSEPH F. FRAUMENI   +3 more
openaire   +1 more source

Recent advances of immunotherapy for biliary tract cancer

Expert Review of Gastroenterology & Hepatology, 2020
Introduction: Biliary tract cancer (BTC) is a heterogeneous group of aggressive malignancies comprising intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, gallbladder cancer, and ampulla of Vater cancer.
A. Rizzo, A. Ricci, G. Brandi
semanticscholar   +1 more source

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.

Journal of Clinical Oncology, 2019
PURPOSE No standard adjuvant treatment currently is recommended in localized biliary tract cancer (BTC) after surgical resection. We aimed to assess whether gemcitabine and oxaliplatin chemotherapy (GEMOX) would increase relapse-free survival (RFS) while
J. Edeline, M. Benabdelghani, A. Bertaut, J. Watelet, P. Hammel, J. Joly, K. Boudjema, L. Fartoux, K. Bouhier‐Leporrier, J. Jouve, R. Faroux, V. Guérin-Meyer, J. Kurtz, E. Assenat, J. Seitz, I. Baumgaertner, D. Tougeron, C. de la Fouchardière, C. Lombard-Bohas, E. Boucher, T. Stanbury, C. Louvet, D. Malka, J. Phelip   +23 more
semanticscholar   +1 more source

[Biliary tract carcinomas. II. Biliary tract cancer].

Vutreshni bolesti, 1982
The authors discuss the biliary tract carcinoma in the second paper on biliary tract carcinomas. It ranks second as regards frequency, being responsible for 4 per cent of the biliary operations. The analysis is based on 48 observations during the period 1952-1979 at the Chair of Abdominal Surgery - 31 males and 17 females (2:1).
A, Merdzhanov, D, Damianov, A, Aleksandrova, G, Evtimov   +3 more
openaire   +1 more source

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet, 2023
K. Nakachi, M. Ikeda, M. Konishi, S. Nomura, H. Katayama, T. Kataoka, A. Todaka, H. Yanagimoto, S. Morinaga, Shogo Kobayashi, K. Shimada, Y. Takahashi, T. Nakagohri, K. Gotoh, K. Kamata, Yasuhiro Shimizu, M. Ueno, H. Ishii, T. Okusaka, J. Furuse, Keiya Okamura, Y. Kawamoto, A. Katanuma, M. Unno, H. Shirakawa, Hironori Yamaguchi, Amane Takahashi, H. Yanagibashi, Naoya Kato, Y. Sakamoto, Y. Kojima, R. Higuchi, N. Sasahira, K. Sano, Y. Sunakawa, Y. Kumamoto, K. Sugimori, T. Nomura, K. Shibuya, I. Makino, K. Yamazaki, N. Mizuno, H. Wada, M. Sekimoto, T. Ajiki, I. Nakamura, I. Miki, Hiroaki Nagano, K. Ohta, T. Okabayashi, M. Furukawa, N. Fujimori   +51 more
semanticscholar   +1 more source

[Biliary tract cancers].

La Revue du praticien, 2001
Biliary tract cancer is the second most common primary hepatobiliary cancer, after hepatocellular carcinoma. The most frequent localisation is the gallbladder. Mean age of diagnosis is 65 years. The exact cause remains unknown despite well documented risk factors. The majority of these tumours are adenocarcinomas. Symptoms, frequently non specific, are
E, Yahchouchi, D, Cherqui
openaire   +1 more source

Risk Factors for Biliary Tract Cancers

American Journal of Gastroenterology, 1999
Little is known regarding risk factors for biliary tract cancer, i.e., gallbladder carcinoma and extrahepatic bile duct carcinoma. This is the first case-control study conducted in the U.S. regarding risk factors for these cancers.In this hospital-based case-control study, we reviewed the medical records of 69 patients with primary biliary tract cancer
Z R, Khan, A I, Neugut, H, Ahsan, J A, Chabot   +3 more
openaire   +2 more sources

Cancer of the Biliary Tract

1989
Cancer of the bile duct system may arise in any part of the biliary tract — from the intrahepatic biliary radicles to the inflow into the duodenum. Cholangiocarcinoma — the tumour derived from bile duct epithelium — originating from the intrahepatic ductal system may be symptomatically and clinically indistinguishable from other solid liver lesions ...
O. Søreide, L. H. Blumgart
openaire   +1 more source

Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.

The Lancet Gastroenterology and Hepatology, 2022
D. Oh, Kyung-Hun Lee, Dae-Won Lee, J. Yoon, Tae-Yong Kim, J. Bang, Ah-Rong Nam, K. Oh, Jae-Min Kim, Young S. Lee, V. Guthrie, P. McCoon, Weimin Li, Song Wu, Qu Zhang, M. Rebelatto, J. W. Kim   +16 more
semanticscholar   +1 more source

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.

The Lancet Oncology, 2021
M. Javle, M. Borad, N. Azad, R. Kurzrock, G. Abou-Alfa, B. George, J. Hainsworth, F. Meric-Bernstam, C. Swanton, C. Sweeney, C. Friedman, R. Bose, D. Spigel, Yong Wang, Jonathan Levy, K. Schulze, V. Cuchelkar, Arisha Patel, H. Burris   +18 more
semanticscholar   +1 more source